Will AbbVie’s $10.9 Billion Acquisition Shape Its Dividend?
AbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Choosing the right monthly auto contribution rate for retirement can balance present needs with future security. Learn how to set a practical, persistent rate now.
18,528 articlesAbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Intuitive Surgical has powered robotic surgery for years, but its stock treaded lower in 2026. This guide breaks down...
Resideo Technologies stock slid after its quarterly update, underscoring how guidance and costs matter as the company...
Institutional demand is intensifying as XRP hovers near key support. Whales running long while, alongside rising open...
International stocks keep crushing U.S. markets, fueling a rotation into developed economies. A low-cost ETF offers a...
Q1 2026 dumped new data on the health tech landscape, revealing who’s thriving, where margins are headed, and how to ...
As May 2026 unfolds, smart investors are looking for durable growth in healthcare. Here are three standout names, why...
May can bring opportunity for defense stocks as budgets rise and technology drives new capabilities. Here are 3 well-...
A major insider purchase often sparks questions about a stock's future. This breakdown examines what the 125,000-shar...
BIT Capital trimmed a large Lemonade stake in the first quarter, revealing how institutional moves can influence vola...
Beazer Homes rebuffs Dream Finders' latest cash bid, arguing the price undervalues its assets and ongoing turnaround....
Space excitement can push stocks higher fast, but gains often fade without lasting fundamentals. Here’s a practical g...